JPWO2021020585A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021020585A5 JPWO2021020585A5 JP2021535473A JP2021535473A JPWO2021020585A5 JP WO2021020585 A5 JPWO2021020585 A5 JP WO2021020585A5 JP 2021535473 A JP2021535473 A JP 2021535473A JP 2021535473 A JP2021535473 A JP 2021535473A JP WO2021020585 A5 JPWO2021020585 A5 JP WO2021020585A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- thieno
- piperidin
- methyl
- oxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025173320A JP2026010092A (ja) | 2019-07-31 | 2025-10-15 | 複素環化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019141699 | 2019-07-31 | ||
| JP2019141699 | 2019-07-31 | ||
| PCT/JP2020/029589 WO2021020585A1 (ja) | 2019-07-31 | 2020-07-31 | 複素環化合物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025173320A Division JP2026010092A (ja) | 2019-07-31 | 2025-10-15 | 複素環化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2021020585A1 JPWO2021020585A1 (https=) | 2021-02-04 |
| JPWO2021020585A5 true JPWO2021020585A5 (https=) | 2023-08-03 |
| JP7764027B2 JP7764027B2 (ja) | 2025-11-05 |
Family
ID=74228959
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021535473A Active JP7764027B2 (ja) | 2019-07-31 | 2020-07-31 | 複素環化合物 |
| JP2025173320A Pending JP2026010092A (ja) | 2019-07-31 | 2025-10-15 | 複素環化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025173320A Pending JP2026010092A (ja) | 2019-07-31 | 2025-10-15 | 複素環化合物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220402935A1 (https=) |
| EP (1) | EP4006037A4 (https=) |
| JP (2) | JP7764027B2 (https=) |
| WO (1) | WO2021020585A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119630667A (zh) * | 2022-07-25 | 2025-03-14 | 细胞基因公司 | 经取代的咪唑并吡嗪化合物作为irak3的配体定向降解剂 |
| WO2024026262A1 (en) * | 2022-07-25 | 2024-02-01 | Celgene Corporation | Substituted pyrazolyl-pyridinyl compounds as ligand directed degraders of irak3 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005017116A1 (de) | 2005-04-13 | 2006-10-26 | Novartis Ag | Hemmstoffe für Inhibitoren von Apoptose Proteinen (IAP) |
| WO2007048224A1 (en) | 2005-10-25 | 2007-05-03 | Aegera Therapeutics Inc. | Iap bir domain binding compounds |
| CN101374829A (zh) | 2005-12-19 | 2009-02-25 | 健泰科生物技术公司 | Iap的抑制剂 |
| TWI504597B (zh) | 2006-03-16 | 2015-10-21 | Pharmascience Inc | 結合於細胞凋亡抑制蛋白（ｉａｐ）之桿狀病毒ｉａｐ重複序列（ｂｉｒ）區域之化合物 |
| CN101535300B (zh) | 2006-05-16 | 2014-05-28 | 埃格拉医疗公司 | Iap bir域结合化合物 |
| PE20110220A1 (es) | 2006-08-02 | 2011-04-11 | Novartis Ag | DERIVADOS DE 2-OXO-ETIL-AMINO-PROPIONAMIDA-PIRROLIDIN-2-IL-SUSTITUIDOS COMO INHIBIDORES DEL ENLACE DE LA PROTEINA Smac AL INHIBIDOR DE LA PROTEINA DE APOPTOSIS |
| WO2008045905A1 (en) | 2006-10-12 | 2008-04-17 | Novartis Ag | Pyrrolydine derivatives as iap inhibitors |
| NZ577150A (en) | 2006-12-19 | 2012-04-27 | Genentech Inc | Imidazopyridine inhibitors of iap |
| WO2008128171A2 (en) | 2007-04-13 | 2008-10-23 | The Regents Of The University Of Michigan | Diazo bicyclic smac mimetics and the uses thereof |
| US20100317593A1 (en) | 2009-06-12 | 2010-12-16 | Astrazeneca Ab | 2,3-dihydro-1h-indene compounds |
| US8283372B2 (en) | 2009-07-02 | 2012-10-09 | Tetralogic Pharmaceuticals Corp. | 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic |
| RU2612521C2 (ru) | 2009-07-06 | 2017-03-09 | Онтории, Инк. | Новые пролекарства нуклеиновых кислот и способы их применения |
| US9271980B2 (en) | 2009-08-03 | 2016-03-01 | Daljit Singh Dhanoa | Deuterium-enriched pyrimidine compounds and derivatives |
| US9284350B2 (en) | 2010-02-12 | 2016-03-15 | Pharmascience Inc. | IAP BIR domain binding compounds |
| JP2012106958A (ja) | 2010-11-18 | 2012-06-07 | Takeda Chem Ind Ltd | 複素環化合物 |
| JP2012176934A (ja) | 2011-02-03 | 2012-09-13 | Takeda Chem Ind Ltd | 複素環化合物 |
| GB201106817D0 (en) | 2011-04-21 | 2011-06-01 | Astex Therapeutics Ltd | New compound |
| US9090624B2 (en) | 2011-08-04 | 2015-07-28 | Allergan, Inc. | Aromatic bycyclic derivatives as CXCR4 receptor modulators |
| JP5934986B2 (ja) | 2011-09-07 | 2016-06-15 | 公益財団法人ヒューマンサイエンス振興財団 | アポトーシス阻害タンパク質リガンド−エストロゲン受容体リガンドハイブリッド化合物並びにそれを利用したエストロゲン受容体分解誘導剤及び乳癌、子宮頚癌又は卵巣癌の予防及び治療剤 |
| NO2755614T3 (https=) | 2012-01-03 | 2018-03-31 | ||
| BR112015001830A2 (pt) | 2012-08-09 | 2017-07-04 | Hoffmann La Roche | composto, uso de um composto, método para o tratamento ou profilaxia de câncer e invenção |
| GB201218850D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
| CA2930030A1 (en) | 2012-11-09 | 2014-05-15 | Ensemble Therapeutics Corporation | Macrocyclic compounds for inhibition of inhibitors of apoptosis |
| CN103242341B (zh) | 2013-04-19 | 2015-12-09 | 中国科学院广州生物医药与健康研究院 | 噻吩并2，4取代嘧啶类化合物及其药物组合物与应用 |
| USRE49687E1 (en) | 2014-09-09 | 2023-10-10 | The Regents Of The University Of Michigan | Thienopyrimidine and thienopyridine compounds and methods of use thereof |
| GB201506872D0 (en) | 2015-04-22 | 2015-06-03 | Ge Oil & Gas Uk Ltd | Novel compounds |
| GB201506871D0 (en) | 2015-04-22 | 2015-06-03 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| BR112017028269A2 (pt) | 2015-07-13 | 2018-09-04 | Arvinas Inc | composto, composição farmacêutica, uso de uma quantidade efetiva de um composto, estado ou condição de doença, e, método para identificar um composto. |
| AU2017253560B2 (en) | 2016-04-20 | 2019-03-21 | Glaxosmithkline Intellectual Property Development Limited | Conjugates comprising RIPK2 inhibitors |
| CN118436801A (zh) | 2016-05-20 | 2024-08-06 | 豪夫迈·罗氏有限公司 | Protac抗体缀合物及其使用方法 |
| GB201610147D0 (en) | 2016-06-10 | 2016-07-27 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| JP6899993B2 (ja) | 2016-10-04 | 2021-07-07 | 国立医薬品食品衛生研究所長 | 複素環化合物 |
| KR20250117470A (ko) | 2016-12-23 | 2025-08-04 | 아비나스 오퍼레이션스, 인코포레이티드 | 급속 진행성 섬유육종 폴리펩티드의 표적화 분해를 위한 화합물 및 방법 |
| US11191741B2 (en) | 2016-12-24 | 2021-12-07 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide |
| EP3710443A1 (en) | 2017-11-17 | 2020-09-23 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of interleukin-1 receptor-associated kinase 4 polypeptides |
| IL315310A (en) | 2017-12-26 | 2024-10-01 | Kymera Therapeutics Inc | Irak degraders and uses thereof |
| WO2020027225A1 (ja) * | 2018-07-31 | 2020-02-06 | ファイメクス株式会社 | 複素環化合物 |
-
2020
- 2020-07-31 JP JP2021535473A patent/JP7764027B2/ja active Active
- 2020-07-31 EP EP20847962.6A patent/EP4006037A4/en active Pending
- 2020-07-31 US US17/630,203 patent/US20220402935A1/en active Pending
- 2020-07-31 WO PCT/JP2020/029589 patent/WO2021020585A1/ja not_active Ceased
-
2025
- 2025-10-15 JP JP2025173320A patent/JP2026010092A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11034685B2 (en) | Aminopyridine derivatives as TAM family kinase inhibitors | |
| CA3089936C (en) | Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agents | |
| CN112707893B (zh) | 作为usp30抑制剂的1-氰基吡咯烷化合物 | |
| ES2898835T3 (es) | Azol amidas y aminas como inhibidores de la integrina alfav | |
| KR20220042204A (ko) | Rip1 억제 화합물 및 그를 제조 및 사용하는 방법 | |
| ES2944657T3 (es) | Compuestos de alqueno como moduladores del receptor farnesoide X | |
| IL258159A (en) | Novel ferroportin inhibitors | |
| WO2018177403A1 (zh) | 1H-咪唑[4,5-h]喹唑啉类化合物作为蛋白激酶抑制剂 | |
| AU2015275730A1 (en) | Substituted indazole compounds as IRAK4 inhibitors | |
| CN111406054A (zh) | 作为组蛋白脱乙酰基酶6抑制剂的1，2，4-噁二唑衍生物 | |
| KR20220079919A (ko) | 헤테로시클릭 rip1 억제 화합물 | |
| US20150051185A1 (en) | Chemical Compounds 251 | |
| WO2014004863A2 (en) | Compounds, compositions, and therapeutic uses thereof | |
| BR112020008157A2 (pt) | compostos espirocíclicos como moduladores do receptor farnesoide x | |
| CA3054945A1 (en) | Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of gpr6 | |
| WO2023049199A1 (en) | Azole compounds | |
| JPWO2021020585A5 (https=) | ||
| WO2017073743A1 (ja) | 三環性化合物 | |
| ES3045034T3 (en) | C-myc mrna translation modulators and uses thereof in the treatment of cancer | |
| TW202320787A (zh) | 一種周期蛋白依賴性激酶抑制劑 | |
| US12565494B2 (en) | Inhibitors of human respiratory syncytial virus and metapneumovirus | |
| TW202409011A (zh) | 人類呼吸道融合病毒及間質肺病毒抑制劑 | |
| TW201247647A (en) | Glycine transport inhibitor | |
| HK40016591A (en) | Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of gpr6 | |
| HK40016591B (en) | Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of gpr6 |